Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation.

Bone marrow transplantation - 1 Mar 1994

Neubauer M A, Benyunes M C, Thompson J A, Bensinger W I, Lindgren C G, Buckner C D, Fefer A

Abstract excerpt

Immunotherapy with interleukin-2 (IL-2) early after peripheral blood stem cell transplantation (PBSCT) is being considered as a potential way to eradicate minimal residual disease. The aim of this study was to determine whether lymphocytes which can acquire lymphokine-activated killer (LAK) cell activity are present in PBSC and in the blood of patients after PBSCT. Fresh and cryopreserved G-CSF-mobilized PBSC...

Topics

Adult
Blood Cells
Blood Component Removal
Blood Transfusion, Autologous
CD4-CD8 Ratio
Cryopreservation
Female
Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cells
Humans

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Interleukin-2

Killer Cells, Lymphokine-Activated

Middle Aged

Monocytes

Phenotype

Time Factors

Source

Open in PubMed

Identifiers

PMID: 7911048

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 29 Aug 2026. Prepared record publication-7911048-2026-08-29.1. Manifest publication-graph-cohort-2026-08-29.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 29 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation.PMID 7911048Read ↗

Human spleen and peripheral blood lymphocytes activated by interleukin-2 have similar phenotypic and functional characteristics.Semantic proximity Read ↗

Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients.Semantic proximity Read ↗

Interleukin-2 after autologous bone marrow transplantation as consolidative immunotherapy against minimal residual disease.Semantic proximity Read ↗

Presence of cytotoxic B220+CD3+CD4-CD8- cells correlates with the therapeutic efficacy of lymphoma treatment with IL-2 and/or IL-12.Semantic proximity Read ↗

Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2.Semantic proximity Read ↗

Cytolytic function of clonable T cells after human bone marrow transplantation.Semantic proximity Read ↗

Lymphokine-activated killer (LAK) cells discriminate between Epstein-Barr virus (EBV)-positive Burkitt's lymphoma cells.Semantic proximity Read ↗

Genesis of human oncolytic natural killer cells from primitive CD34+CD33- bone marrow progenitors.Semantic proximity Read ↗

Reconstitution of the cellular immune response after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin's lymphoma.Semantic proximity Read ↗

Interleukin-2 activation of human bone marrow in long-term cultures: an effective strategy for purging and generation of anti-tumor cytotoxic effectors.Semantic proximity Read ↗

Lymphokine-activated killer (LAK) cells modulate the effects of IL-2 on a T cell-mediated immune response.Semantic proximity Read ↗

Development of four donor-specific phenotypes in human long-term lymphokine-activated killer cell cultures.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.